1. Home
  2. PODD vs ERIE Comparison

PODD vs ERIE Comparison

Compare PODD & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • ERIE
  • Stock Information
  • Founded
  • PODD 2000
  • ERIE 1925
  • Country
  • PODD United States
  • ERIE United States
  • Employees
  • PODD N/A
  • ERIE N/A
  • Industry
  • PODD Medical/Dental Instruments
  • ERIE Specialty Insurers
  • Sector
  • PODD Health Care
  • ERIE Finance
  • Exchange
  • PODD Nasdaq
  • ERIE Nasdaq
  • Market Cap
  • PODD 21.5B
  • ERIE 19.4B
  • IPO Year
  • PODD 2007
  • ERIE 1995
  • Fundamental
  • Price
  • PODD $299.96
  • ERIE $352.79
  • Analyst Decision
  • PODD Strong Buy
  • ERIE
  • Analyst Count
  • PODD 19
  • ERIE 0
  • Target Price
  • PODD $320.11
  • ERIE N/A
  • AVG Volume (30 Days)
  • PODD 858.4K
  • ERIE 145.4K
  • Earning Date
  • PODD 08-07-2025
  • ERIE 07-24-2025
  • Dividend Yield
  • PODD N/A
  • ERIE 1.54%
  • EPS Growth
  • PODD 67.46
  • ERIE 26.84
  • EPS
  • PODD 5.55
  • ERIE 11.75
  • Revenue
  • PODD $2,198,900,000.00
  • ERIE $3,903,813,000.00
  • Revenue This Year
  • PODD $24.49
  • ERIE $11.70
  • Revenue Next Year
  • PODD $17.45
  • ERIE $7.83
  • P/E Ratio
  • PODD $54.05
  • ERIE $30.10
  • Revenue Growth
  • PODD 23.48
  • ERIE 14.91
  • 52 Week Low
  • PODD $173.00
  • ERIE $333.33
  • 52 Week High
  • PODD $329.33
  • ERIE $547.00
  • Technical
  • Relative Strength Index (RSI)
  • PODD 53.70
  • ERIE 41.16
  • Support Level
  • PODD $305.07
  • ERIE $333.33
  • Resistance Level
  • PODD $316.00
  • ERIE $348.22
  • Average True Range (ATR)
  • PODD 6.33
  • ERIE 7.22
  • MACD
  • PODD -0.34
  • ERIE -0.60
  • Stochastic Oscillator
  • PODD 69.72
  • ERIE 37.27

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

Share on Social Networks: